H. Al-Hiti Et Al. , "Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial," The Lancet Respiratory Medicine , vol.9, no.6, pp.573-584, 2021
Al-Hiti, H. Et Al. 2021. Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. The Lancet Respiratory Medicine , vol.9, no.6 , 573-584.
Al-Hiti, H., Benza, R. L., Chang, S., Gibbs, J. S. R., Grünig, E., Jansa, P., ... Klinger, J. R.(2021). Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial. The Lancet Respiratory Medicine , vol.9, no.6, 573-584.
Al-Hiti, Hikmet Et Al. "Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial," The Lancet Respiratory Medicine , vol.9, no.6, 573-584, 2021
Al-Hiti, Hikmet Et Al. "Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial." The Lancet Respiratory Medicine , vol.9, no.6, pp.573-584, 2021
Al-Hiti, H. Et Al. (2021) . "Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial." The Lancet Respiratory Medicine , vol.9, no.6, pp.573-584.
@article{article, author={Hikmet Al-Hiti Et Al. }, title={Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial}, journal={The Lancet Respiratory Medicine}, year=2021, pages={573-584} }